Evidence map›Paper›PMID 41320285›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2025

Primary large B-cell lymphoma of the central nervous system mimicking inflammatory myelitis at initial presentation.

Satoshi Ichikawa, Katsuki Imanishi, Hikaru Kumagai, Shunsuke Hatta, Yoko Okitsu, Masahiro Kobayashi, Narumi Okajima, Dai Ichikawa, Fumiyoshi Fujishima, Junichi Kameoka and 1 more

Abstract readCase Reports
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Satoshi IchikawaDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Katsuki ImanishiDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Hikaru KumagaiDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Shunsuke HattaDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Yoko OkitsuDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Masahiro KobayashiDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Narumi OkajimaDivision of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Dai IchikawaDivision of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Fumiyoshi FujishimaDivision of Pathology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Junichi KameokaDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Tomonori IshiiDivision of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary central nervous system large B-cell lymphoma (PCNS-LBCL) is a rare extranodal non-Hodgkin lymphoma that typically affects the brain parenchyma. Spinal cord involvement as an initial manifestation is extremely uncommon and poses considerable diagnostic challenges, often mimicking inflammatory demyelinating diseases. We report the case of a man in his late 50s who initially presented with steroid-responsive cervical myelitis, resulting in a provisional diagnosis of multiple sclerosis. Despite treatment with corticosteroids and ofatumumab, the patient experienced neurological deterioration and developed cerebellar lesions. Stereotactic brain biopsy confirmed PCNS-LBCL. Although the initial spinal lesion may have represented a definite lymphoma, it was also considered a sentinel lesion, a non-neoplastic inflammatory precursor occasionally observed in PCNSL. This case highlights the diagnostic complexity of PCNS-LBCL presenting with isolated spinal involvement and steroid responsiveness, both of which may delay appropriate treatment. Notably, cerebrospinal fluid analysis at the time of initial presentation of spinal lesions revealed elevated interleukin-10 levels, which declined substantially following chemotherapy, correlating with clinical improvement. Clinicians should maintain a high index of suspicion for central nervous system lymphoma in cases of relapsing myelitis unresponsive to conventional immunotherapy and consider timely biopsy when clinically feasible. Heightened awareness of sentinel lesions may facilitate early recognition and improve outcomes in patients with PCNSL.

Indexed as

Central Nervous System NeoplasmsLymphoma, Large B-Cell, DiffuseMyelitisDiagnosis, DifferentialHumansMagnetic Resonance ImagingMaleMiddle Ageddiagnostic delayinflammatory demyelinating diseaseinterleukin-10primary central nervous system large B-cell lymphomasentinel lesion

Identifiers

PMID41320285
PMCPMC12883026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.